Mendelian randomization analysis reveals potential causal relationships between serum lipid metabolites and prostate cancer risk

This study provides important insights into the complex relationship between serum lipid metabolites and prostate cancer risk. Although most lipid metabolites may not be strong determinants of prostate cancer risk, certain specific metabolites may have weak associations.